Skip to main content
Article thumbnail
Location of Repository

Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new

By Mary Dixon-Woods, Rene Amalberti, Steve Goodman, Bo Bergman and Paul Glasziou


Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or pose risks, while other innovations that could potentially deliver benefits to patients remain slow to achieve uptake. Second, participatory, cooperative approaches may be the best way of achieving sustainable, positive innovation, yet relying solely on such approaches may disrupt positive innovation. Third, improvement clearly depends upon change, but change always generates new challenges. Quality improvement systems may struggle to keep up with the pace of innovation, yet evaluation of innovation is often too narrowly focused for the system-wide effects of new practices or technologies to be understood. A new recognition of the problems of innovation is proposed and it is argued that new approaches to addressing them are needed

Publisher: BMJ Publishing Group
Year: 2011
DOI identifier: 10.1136/bmjqs.2010.046227
OAI identifier:

Suggested articles


  1. (2004). Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q doi
  2. (2001). External validity. In: doi
  3. (1998). Group Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ doi
  4. Heterogeneity is not always noise: lessons from improvement. doi
  5. Laetrile treatment for cancer. Cochrane Database Syst Rev 2006;(2):CD005476. doi:10.1002/ doi
  6. (2005). Long-term 5-year followup of the results of the vesica procedure. doi
  7. (2009). Managing expert knowledge: organizational challenges and managerial futures for the UK medical profession. Organization Studies doi
  8. (2002). Managing networks: propositions on what managers do and why they do it. Public Adm Rev doi
  9. (2001). Managing the care of health and the cure of diseasedPart I: differentiation. Health Care Manage Rev doi
  10. Professional work: the emergence of collaborative community.
  11. (2003). Resisting evidence: the study of evidence-based medicine as a contemporary social movement. Health doi
  12. (2011). Saf 2011;20(Suppl 1):i47ei51. doi:10.1136/bmjqs.2010.046227 i51 The social determinants of action on
  13. (2000). Seeing organizational learning: a ‘cultural’ view. Organization doi
  14. (1994). Strategies for Cultural Change. doi
  15. The Courage to Fail: A Social View of Organ Transplants and Dialysis. doi
  16. (1998). The dynamics of multi-organizational partnerships. Public Adm doi
  17. (1981). The framing of decisions and the psychology of choice. Science doi
  18. (1989). The imperative character of medical technology and the meaning of ‘anticipated decision regret.’ doi
  19. (1996). The new governance: governing without government. Polit Stud doi
  20. (2008). The regulatory state. In: Rhodes doi
  21. (2006). Toward ethical review of health system transformations. doi
  22. (2000). Using technology and constituting structures: a practice lens for studying technology in organizations. Organ Sci doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.